Smoking during pregnancy

Smoking during pregnancy is an important preventable risk factor for pregnancy complications and is associated with poorer perinatal outcomes. Supporting women to stop smoking during pregnancy can reduce the risk of adverse outcomes for mothers and their babies. Support to stop smoking is widely available through antenatal clinics. For more information, see Clinical commentary.

This indicator examines the number of all women who gave birth who reported smoking in the first 20 weeks of pregnancy and those who reported continuing to smoke after the first 20 weeks of pregnancy.

Key findings

  • Around 1 in 13 women (7.6%) giving birth in 2023 reported smoking in the first 20 weeks of pregnancy, with over two thirds of these women (69%) reporting continuing to smoke after the first 20 weeks of pregnancy.
  • The proportion of women reporting smoking in the first 20 weeks of pregnancy declined from 13% in 2011 to 7.6% in 2023, while the proportion of women continuing to smoke after the first 20 weeks of pregnancy has fluctuated between 69% and 76% over the period 2011 to 2023.

The proportion of women reporting smoking in the first 20 weeks of pregnancy:

  • generally declined with increasing age, with women younger than 20 having the highest smoking rates (29% in 2023)
  • was highest for women living in areas of most disadvantage and lowest for women living in areas of least disadvantage
  • was highest for women living in Very remote areas and lowest for women living in Major cities.

The interactive data visualisation (Figure 4) presents data on women who reported smoking in the first 20 weeks of pregnancy and for those who reported continuing smoking after the first 20 weeks. Use the drop-down menus to view data by selected characteristics and the latest year button to explore data for 2023.

Figure 4: Smoking during pregnancy

This data visualisation presents data on women smoking during pregnancy. Interactive charts show proportions for the most recent data and over time, for selected demographic and birth characteristics.

This data visualisation presents data on women smoking during pregnancy. Interactive charts show proportions for the most recent data and over time, for selected demographic and birth characteristics.

Clinical commentary

Women who smoke tobacco during pregnancy are more likely to experience pre-term birth, placental complications and perinatal death of their baby (WHO 2013). 

Babies of mothers who smoke during pregnancy are at increased risk of poor growth during pregnancy, particularly during the phase of rapid weight gain from 34 weeks of gestation onwards (Sirvinskiene et al. 2016). Sudden infant death syndrome, childhood diabetes and childhood obesity have been linked with exposure to tobacco during fetal development (Banderali et al. 2015; Flenady et al. 2018). Maternal smoking is associated with low birthweight, which in turn is associated with poor educational outcomes in early childhood, coronary heart disease, type 2 diabetes, and being overweight in adulthood (Guthridge et al. 2015; Lumley et al. 2009).

Smoking cessation during pregnancy is key in reducing the risk of complications during pregnancy and birth as well as reducing adverse health outcomes for the baby. Cessation at later stages of pregnancy will still improve health outcomes for the baby, including improved fetal growth (AIHW 2021; Miyazaki et al. 2015).

There are clear associations between smoking in pregnancy, age of the mother, remoteness of residence and disadvantage quintile evident in the results presented. Varying socio-demographic profiles of women who give birth in public and private hospitals need to be taken into account when considering the higher rates of smoking in pregnancy for women giving birth in public hospitals.

Indicator specifications and data

Excel source data tables are available from Data.

For more information, refer to Data specifications and Methods.